BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9590239)

  • 1. Activation of the CD2 pathway in lamina propria T cells up-regulates functionally active AP-1 binding to the IL-2 promoter, resulting in messenger RNA transcription and IL-2 secretion.
    Gonsky R; Deem RL; Hughes CC; Targan SR
    J Immunol; 1998 May; 160(10):4914-22. PubMed ID: 9590239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28 costimulation augments IL-2 secretion of activated lamina propria T cells by increasing mRNA stability without enhancing IL-2 gene transactivation.
    Gonsky R; Deem RL; Lee DH; Chen A; Targan SR
    J Immunol; 1999 Jun; 162(11):6621-9. PubMed ID: 10352279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD2 mediates activation of the IFN-gamma intronic STAT binding region in mucosal T cells.
    Gonsky R; Deem RL; Young HA; Targan SR
    Eur J Immunol; 2003 May; 33(5):1152-62. PubMed ID: 12731040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costimulation of peripheral blood T cell activation by human endothelial cells. Enhanced IL-2 transcription correlates with increased c-fos synthesis and increased Fos content of AP-1.
    Hughes CC; Pober JS
    J Immunol; 1993 Apr; 150(8 Pt 1):3148-60. PubMed ID: 8468462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT.
    Whisler RL; Beiqing L; Chen M
    Cell Immunol; 1996 May; 169(2):185-95. PubMed ID: 8620546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells.
    Beiqing L; Chen M; Whisler RL
    J Immunol; 1996 Jul; 157(1):160-9. PubMed ID: 8683110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
    Whisler RL; Chen M; Beiqing L; Carle KW
    Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro analysis of interferon gamma (IFN-gamma) and interleukin-12 (IL-12) production and their effects in ileal Crohn's disease.
    Colpaert S; Vastraelen K; Liu Z; Maerten P; Shen C; Penninckx F; Geboes K; Rutgeerts P; Ceuppens JL
    Eur Cytokine Netw; 2002; 13(4):431-7. PubMed ID: 12517728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the AP-1 sites in the IL-2 promoter.
    Jain J; Valge-Archer VE; Rao A
    J Immunol; 1992 Feb; 148(4):1240-50. PubMed ID: 1737937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional control of IL-2 and IL-4 in T cells of young and old mice.
    Albright JW; Zúñiga-Pflücker JC; Albright JF
    Cell Immunol; 1995 Sep; 164(2):170-5. PubMed ID: 7656324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells.
    Iwai K; Mori N; Oie M; Yamamoto N; Fujii M
    Virology; 2001 Jan; 279(1):38-46. PubMed ID: 11145887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosa-specific targets for regulation of IFN-gamma expression: lamina propria T cells use different cis-elements than peripheral blood T cells to regulate transactivation of IFN-gamma expression.
    Gonsky R; Deem RL; Bream JH; Lee DH; Young HA; Targan SR
    J Immunol; 2000 Feb; 164(3):1399-407. PubMed ID: 10640755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome.
    Cianferoni A; Massaad M; Feske S; de la Fuente MA; Gallego L; Ramesh N; Geha RS
    J Allergy Clin Immunol; 2005 Dec; 116(6):1364-71. PubMed ID: 16337472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic inflammation: mechanisms regulating IL-5 transcription in human T lymphocytes.
    Wang J; Young IG
    Allergy; 2007 Oct; 62(10):1131-8. PubMed ID: 17845581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I augments interleukin-8 promoter activity through induction of activator protein-1 complex formation.
    Kooijman R; Coppens A; Van den Keybus C
    Int J Biochem Cell Biol; 2006; 38(11):1957-64. PubMed ID: 16846747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive effect of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through the inhibition of T-lymphocyte proliferation and IL-2 production.
    Yun CH; Son CG; Jung U; Han SH
    Toxicology; 2006 Jan; 217(1):31-8. PubMed ID: 16168555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta 1 (TGF-beta1) promotes IL-2 mRNA expression through the up-regulation of NF-kappaB, AP-1 and NF-AT in EL4 cells.
    Han SH; Yea SS; Jeon YJ; Yang KH; Kaminski NE
    J Pharmacol Exp Ther; 1998 Dec; 287(3):1105-12. PubMed ID: 9864299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of p65 and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter.
    Parra E; McGuire K; Hedlund G; Dohlsten M
    J Immunol; 1998 Jun; 160(11):5374-81. PubMed ID: 9605137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced basal AP-1 activity and de-regulation of numerous genes in T cells transgenic for a dominant interfering mutant of FADD/MORT1.
    Chaneva S; Schneider G; Siegmund D; Wajant H; Mages J; Häcker G
    Eur J Immunol; 2004 Nov; 34(11):3006-15. PubMed ID: 15376191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.